Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

44,651 stories, page 615 of 745

Advanced search

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

How a ‘Chinese heart’ could get US blood pumping despite biotech decoupling

South China Morning PostOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Abivax expands obefazimod safety data ahead of FDA filing

The Pharma LetterOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Kapihan Session Convenes Media and Biotech Experts for a Dialogue on Agricultural Biotechnology

ISAAA.orgOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

The Quiet Winner Behind the AI Trade: Biotech’s 2026 Comeback

MoomooOriginal source

🇺🇰Jul 1Regulatorygov.ukTier 1 · Regulatory source

National Chlamydia Screening Programme (NCSP): incident reporting policy

Policy to report incidents during delivery of chlamydia screening to the UK Health Security Agency (...

UK Health Security AgencyOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of China Resources Pharmaceutical Group Ltd. – HKEX:3320

TradingViewOriginal source

🌍Jul 1discoverynews.google.comTier 2 · Trade media

Beyond the GLP-1RA weight loss ceiling

Pharmaceutical TechnologyOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Massachusetts biotech layoffs drop to lowest level in over two years

The Business JournalsOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Tracking Cathie Wood: Doubling Down on AI-Biotech and Crypto, Retreating From Genomics and China Tech

MoomooOriginal source

🌍Jul 1discoverynews.google.comTier 2 · Trade media

Backed by top VCs, biotech bags Alzheimer’s med in $2.2B deal

Fierce BiotechOriginal source

🇺🇰Jul 1Regulatorygov.ukTier 1 · Regulatory source

RSV vaccination: expansion of eligibility to older adults in certain clinical risk groups

Information on the expansion of the eligibility criteria of the older adults respiratory syncytial v...

UK Health Security AgencyOriginal source

🇺🇰Jul 1Regulatorygov.ukTier 1 · Regulatory source

Pre-release access list: monthly HCAI statistical release

List of those receiving pre-release access to the monthly UK Health Security Agency mandatory health...

UK Health Security AgencyOriginal source

🇺🇰Jul 1Regulatorygov.ukTier 1 · Regulatory source

National Child Measurement Programme: operational guidance

Guidance on running the National Child Measurement Programme, which collects the height and weight o...

UK Department of Health and Social CareOriginal source

🇺🇰Jul 1Regulatorygov.ukTier 1 · Regulatory source

National Child Measurement Programme: information for schools

Information to help schools support the delivery of the National Child Measurement Programme to meas...

UK Department of Health and Social CareOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Ipsen acquires Swiss-based Memo Therapeutics

medwatch.comOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical Companies Target Fat-Reducing Injections Amid Growing Demand

Aju PressOriginal source

🇩🇰Jul 1Researchhealthsciences.ku.dkTier 2 · Direct publisher

ADHD and autism diagnoses have increased: New study points to broader diagnoses as an explanation

University of Copenhagen - HealthOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

FDA seizes adulterated milk, dairy products and sweets worth Rs 13.71 lakh

Mid-dayOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

HIMS Stock Slips Overnight After FDA Staff Questions Safety Of Popular Peptides — But One Analyst Says ‘This Isn’t The End’

TradingViewOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

IMCD opens new Pharmaceutical Technical Centre in New Jersey

Manufacturing ChemistOriginal source

🌍Jul 1discoverynews.google.comTier 2 · Trade media

Golden Triangle still dominates, but talent and capital gaps slow biotech growth

BioSpaceOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Chugai Pharmaceutical Opens South San Francisco Research Hub to Facilitate Academic Collaborations

geneonline.comOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Nicox’s NCX 470 New Drug Application Submitted in the United States by Kowa, with Associated €3 million Milestone Payment

The Manila TimesOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Nicox’s NCX 470 New Drug Application Submitted in the United States by Kowa, with Associated €3 million Milestone Payment

Yahoo Finance SingaporeOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Axsome advances solriamfetol into Phase 3 trial in adolescent ADHD as first patient is dosed

Indian Pharma PostOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

French biotech Ipsen to buy Memo Therapeutics for $230 million upfront

TradingViewOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

New Haven biotech company developing measles treatment as US cases top 2,100

WFSBOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Kirsten Detrick: A connective tissue across biotech

Healthcare TodayOriginal source

🇪🇺Jul 1Associationeucope.orgTier 2 · Direct publisher

EUCOPE strengthens its expertise on Joint Clinical Assessments with the appointment of Dr. Thomas Ecker

EUCOPEOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Trinity Biotech’s Trinovium Secures Open Compute Project Membership, Advancing Hyperscale Market Access and Commercial Validation for AI Data Center Liquid Cooling

AI MagazineOriginal source

🌍Jul 1discoverynews.google.comTier 2 · Trade media

Aspen Neuroscience Announces Completion of Cohort 3 and 4 Dosing in Aspiro Phase 1/2a Trial of Sasineprocel for Parkinson's Disease

BioSpaceOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

AriBio Independently Completes Global Phase 3 Trial of Oral Alzheimer's Drug Candidate 'AR1001'

더바이오Original source

🌍Jul 1Industrymenicon.comTier 1 · Company source

- Menicon Group strengthens its sales foundation in eastern Japan and creates new customer touchpoints -Announcement of stock acquisition of Inter-Optical Co., Ltd.

MeniconOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Shoko Co., Ltd. Began Commercial Production of Pharmaceutical Excipient “Viscomedi” at Its South Korean Plant

Business WireOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

ABVX Stock Clocks Best Day In 11 Months On Analyst Upgrades After Fresh Data Eases Drug Safety Concerns

TradingViewOriginal source

🌍Jul 1discoverynews.google.comTier 3 · Aggregated media

Recce Pharmaceuticals bolsters cash position with A$3.67 million tax refund ahead of Phase 3 milestones

Proactive financial newsOriginal source

🇺🇸Jul 1Regulatorysec.govTier 1 · Regulatory source

AstraZeneca filed Form 6-K

SEC EDGAROriginal source

🇺🇸Jul 1Regulatorysec.govTier 1 · Regulatory source

Biogen filed Form 8-K

SEC EDGAROriginal source

🇺🇸Jul 1Regulatorysec.govTier 1 · Regulatory source

GSK filed Form 6-K

SEC EDGAROriginal source

🇺🇰Jul 1Regulatorynice.org.ukTier 1 · Regulatory source

New draft PMOS guideline recommends annual review and could mean quicker diagnosis

NICEOriginal source

🇿🇦Jul 1Researchnews.uct.ac.zaTier 2 · Direct publisher

Putting communities at the centre of technology

University of Cape TownOriginal source

🇺🇸Jul 1Regulatoryfederalregister.govTier 1 · Regulatory source

Schedules of Controlled Substances: Temporary Placement of 5,6- Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act

The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish...

Federal RegisterOriginal source

🇺🇸Jul 1Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medication Guides for Prescription Drug Products

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has b...

Federal RegisterOriginal source

🇺🇸Jul 1Regulatoryfederalregister.govTier 1 · Regulatory source

Center for Scientific Review; Notice of Closed Meetings

Federal RegisterOriginal source

🇺🇸Jul 1Regulatoryfederalregister.govTier 1 · Regulatory source

Lists of Designated Primary Medical Care, Mental Health, and Dental Health Professional Shortage Areas

This notice informs the public of the availability of the complete lists of all geographic areas, po...

Federal RegisterOriginal source

🇺🇸Jul 1Regulatoryfederalregister.govTier 1 · Regulatory source

Notice of Proposed Purchased/Referred Care Delivery Area Redesignation for Ysleta Del Sur Pueblo

This notice advises the public that the Indian Health Service (IHS) proposes to expand the geographi...

Federal RegisterOriginal source

🇺🇸Jul 1Regulatoryfederalregister.govTier 1 · Regulatory source

Modification of Living Organ Donation Reimbursement Program Eligibility Guidelines in Response To Honor Our Living Donors Act

HRSA proposes to modify the eligibility guidelines for the Living Organ Donation Reimbursement Progr...

Federal RegisterOriginal source

🇺🇸Jul 1Regulatoryfederalregister.govTier 1 · Regulatory source

The Federal Demonstration Partnership; Phase VIII Notice

This notice announces a solicitation for large and small public and private colleges and universitie...

Federal RegisterOriginal source

🇺🇸Jul 1Regulatoryfederalregister.govTier 1 · Regulatory source

Rural Health Innovation and Transformation Technical Assistance

HRSA will provide additional award funds to the Rural Health Innovation and Transformation Technical...

Federal RegisterOriginal source

🇺🇸Jul 1Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: National Marrow Donor Program Patient Support Center Survey

In compliance with the requirement for opportunity for public comment on proposed data collection pr...

Federal RegisterOriginal source

🇺🇸Jul 1Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Kids Mineral Face Cream SPF20

Official structured record identifier: fbfccb0c-e459-3282-e053-6394a90ad95d.

openFDA Drug LabelsOriginal source

🇺🇸Jul 1Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Nicotine Transdermal System step 3

Official structured record identifier: e51d2c09-a20f-eb9b-e3e4-013f3e488ab3.

openFDA Drug LabelsOriginal source

🇺🇸Jul 1Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Zinc Oxide 20%

Official structured record identifier: c2e57236-f184-4fa8-8fd5-c44cbf230058.

openFDA Drug LabelsOriginal source

🇺🇸Jul 1Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Evereden Kids Mineral Sunscreen SPF 30

Official structured record identifier: bba219a4-de83-76fd-e053-2995a90a2d69.

openFDA Drug LabelsOriginal source

🇺🇸Jul 1Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: METFORMIN HYDROCHLORIDE

Official structured record identifier: a944a167-e3ac-4084-af1c-22b48713471c.

openFDA Drug LabelsOriginal source

🇺🇸Jul 1Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Oxybutynin Chloride

Official structured record identifier: 9ede5def-d185-4e40-9c10-8663ac654caf.

openFDA Drug LabelsOriginal source

🇺🇸Jul 1Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Bumetanide

Official structured record identifier: 9058fc52-f3f6-4d7f-b2a0-b1e2c714b133.

openFDA Drug LabelsOriginal source

🇺🇸Jul 1Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: olanzapine

Official structured record identifier: 8f485576-a4c4-45d4-816f-2e59fce9f517.

openFDA Drug LabelsOriginal source

🇺🇸Jul 1Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: 8 HR Arthritis Pain

Official structured record identifier: 8e780c23-997c-b960-226e-954037baad4b.

openFDA Drug LabelsOriginal source

🇺🇸Jul 1Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: ESTRADIOL

Official structured record identifier: 5c9a2e0f-704b-4d16-8ea3-d94f7f36ce6b.

openFDA Drug LabelsOriginal source

Pharmaceutical industry news

How a ‘Chinese heart’ could get US blood pumping despite biotech decoupling

Abivax expands obefazimod safety data ahead of FDA filing

Kapihan Session Convenes Media and Biotech Experts for a Dialogue on Agricultural Biotechnology

The Quiet Winner Behind the AI Trade: Biotech’s 2026 Comeback

National Chlamydia Screening Programme (NCSP): incident reporting policy

Price to earnings forward of China Resources Pharmaceutical Group Ltd. – HKEX:3320

Beyond the GLP-1RA weight loss ceiling

Massachusetts biotech layoffs drop to lowest level in over two years

Tracking Cathie Wood: Doubling Down on AI-Biotech and Crypto, Retreating From Genomics and China Tech

Backed by top VCs, biotech bags Alzheimer’s med in $2.2B deal

RSV vaccination: expansion of eligibility to older adults in certain clinical risk groups

Pre-release access list: monthly HCAI statistical release

National Child Measurement Programme: operational guidance

National Child Measurement Programme: information for schools

Ipsen acquires Swiss-based Memo Therapeutics

Pharmaceutical Companies Target Fat-Reducing Injections Amid Growing Demand

ADHD and autism diagnoses have increased: New study points to broader diagnoses as an explanation

FDA seizes adulterated milk, dairy products and sweets worth Rs 13.71 lakh

HIMS Stock Slips Overnight After FDA Staff Questions Safety Of Popular Peptides — But One Analyst Says ‘This Isn’t The End’

IMCD opens new Pharmaceutical Technical Centre in New Jersey

Golden Triangle still dominates, but talent and capital gaps slow biotech growth

Chugai Pharmaceutical Opens South San Francisco Research Hub to Facilitate Academic Collaborations

Nicox’s NCX 470 New Drug Application Submitted in the United States by Kowa, with Associated €3 million Milestone Payment

Nicox’s NCX 470 New Drug Application Submitted in the United States by Kowa, with Associated €3 million Milestone Payment

Axsome advances solriamfetol into Phase 3 trial in adolescent ADHD as first patient is dosed

French biotech Ipsen to buy Memo Therapeutics for $230 million upfront

New Haven biotech company developing measles treatment as US cases top 2,100

Kirsten Detrick: A connective tissue across biotech

EUCOPE strengthens its expertise on Joint Clinical Assessments with the appointment of Dr. Thomas Ecker

Trinity Biotech’s Trinovium Secures Open Compute Project Membership, Advancing Hyperscale Market Access and Commercial Validation for AI Data Center Liquid Cooling

Aspen Neuroscience Announces Completion of Cohort 3 and 4 Dosing in Aspiro Phase 1/2a Trial of Sasineprocel for Parkinson's Disease

﻿AriBio Independently Completes Global Phase 3 Trial of Oral Alzheimer's Drug Candidate 'AR1001'

- Menicon Group strengthens its sales foundation in eastern Japan and creates new customer touchpoints -Announcement of stock acquisition of Inter-Optical Co., Ltd.

Shoko Co., Ltd. Began Commercial Production of Pharmaceutical Excipient “Viscomedi” at Its South Korean Plant

ABVX Stock Clocks Best Day In 11 Months On Analyst Upgrades After Fresh Data Eases Drug Safety Concerns

Recce Pharmaceuticals bolsters cash position with A$3.67 million tax refund ahead of Phase 3 milestones

AstraZeneca filed Form 6-K

Biogen filed Form 8-K

GSK filed Form 6-K

New draft PMOS guideline recommends annual review and could mean quicker diagnosis

Putting communities at the centre of technology

Schedules of Controlled Substances: Temporary Placement of 5,6- Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medication Guides for Prescription Drug Products

Center for Scientific Review; Notice of Closed Meetings

Lists of Designated Primary Medical Care, Mental Health, and Dental Health Professional Shortage Areas

Notice of Proposed Purchased/Referred Care Delivery Area Redesignation for Ysleta Del Sur Pueblo

Modification of Living Organ Donation Reimbursement Program Eligibility Guidelines in Response To Honor Our Living Donors Act

The Federal Demonstration Partnership; Phase VIII Notice

Rural Health Innovation and Transformation Technical Assistance

Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: National Marrow Donor Program Patient Support Center Survey

Drug label update: Kids Mineral Face Cream SPF20

Drug label update: Nicotine Transdermal System step 3

Drug label update: Zinc Oxide 20%

Drug label update: Evereden Kids Mineral Sunscreen SPF 30

Drug label update: METFORMIN HYDROCHLORIDE

Drug label update: Oxybutynin Chloride

Drug label update: Bumetanide

Drug label update: olanzapine

Drug label update: 8 HR Arthritis Pain

Drug label update: ESTRADIOL

AriBio Independently Completes Global Phase 3 Trial of Oral Alzheimer's Drug Candidate 'AR1001'